Literature DB >> 7246581

Calcification in end-stage kidneys.

L S Ibels, A C Alfrey, W E Huffer, P W Craswell, R Weil.   

Abstract

This study was carried out to determine the frequency and to quantitate the severity calcium-phosphate deposits in end-stage kidneys. In 57 of 59 end-stage kidneys obtained from patients with a variety of different renal diseases, calcium levels were greater than 2 standard deviations (SD) above control values. The mean calcium concentration was 157 +/- 24 mmol/kg dry defatted tissue in the end-stage kidneys as compared to 17 +/- 1 mmol/kg in the control kidneys. Histologically, calcium was deposited in the cortical tubular cells, basement membranes and interstitium. It would appear that calcification occurred during the course of renal failure rather thant terminally in that the kidney calcium concentration bore no relationship to the calcium X phosphate product, and the calcium concentration in the kidneys of uremic patients undergoing dialysis (144 +/- 23 mmol/kg) was no greater than that found in uremic patients not undergoing dialysis (188 +/- 62 mmol/kg). It is suggested that calcification may damage the diseased kidney accelerating the rate of renal functional deterioration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7246581     DOI: 10.1016/0002-9343(81)90255-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Interventions in chronic renal failure.

Authors:  J R Curtis
Journal:  BMJ       Date:  1990-09-29

2.  Posttransplant nephrocalcinosis is associated with poor renal allograft function: a single-center experience.

Authors:  Abdul Moiz; Tariq Javed; Jorge Garces; Adriana Dornelles; Catherine Staffeld-Coit
Journal:  Ochsner J       Date:  2015

3.  Prevention of parathyroid hormone-dependent nephrocalcinosis by chronic administration of the organic phosphorothioate WR-2721.

Authors:  S Hirschel-Scholz; J Caverzasio; J P Bonjour
Journal:  Calcif Tissue Int       Date:  1987-02       Impact factor: 4.333

4.  Renal matrix Gla protein expression increases progressively with CKD and predicts renal outcome.

Authors:  Kana N Miyata; Cynthia C Nast; Tiane Dai; Ramanath Dukkipati; Janine A LaPage; Jonathan P Troost; Leon J Schurgers; Matthias Kretzler; Sharon G Adler
Journal:  Exp Mol Pathol       Date:  2018-07-06       Impact factor: 3.362

5.  Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria.

Authors:  Yi-Wen Chiu; Sharon Adler; Matthew Budoff; Junichiro Takasu; Jamila Ashai; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-12       Impact factor: 8.237

6.  No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.

Authors:  Rajnish Mehrotra; Carmen A Peralta; Shu-Cheng Chen; Suying Li; Michael Sachs; Anuja Shah; Keith Norris; Georges Saab; Adam Whaley-Connell; Bryan Kestenbaum; Peter A McCullough
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

7.  The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).

Authors:  H E Eliahou; D Cohen; A Ben-David; D Herzog; I Serban; S Gavendo; S Kapuler; N Kogan; B Hellberg
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.